Last quarter (Q ), G Medical Innovations Holdings's total revenue was $―, a decrease of ― from the same quarter last year. In Q, G Medical Innovations Holdings's net income was $―. See G Medical Innovations Holdings’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
Total Revenue	-	$ 4.42M	$ 4.96M	$ 4.90M	$ 7.89M	$ 4.34M
Cost of Revenue	-	$ 113.00K	$ 66.00K	$ 4.23M	$ 8.21M	$ 5.71M
Gross Profit	-	$ 4.31M	$ 4.89M	$ 667.00K	$ -318.30K	$ -1.37M
Operating Expense	-	$ 32.27M	$ 16.97M	$ 12.67M	$ 17.93M	$ 22.97M
Operating Income	-	$ -27.96M	$ -12.07M	$ -12.00M	$ -18.24M	$ -24.35M
Net Non Operating Interest Income Expense	-	$ 17.55M	$ 870.00K	$ -406.00K	$ -5.12M	$ -194.11K
Other Income Expense	-	$ -11.11M	$ -14.76M	$ -296.00K	-	-
Pretax Income	-	$ 10.69M	$ 3.55M	$ -12.71M	$ -23.36M	$ -24.54M
Tax Provision	-	$ 16.00K	$ 3.38M	$ -18.00K	$ -1.22M	$ -488.81K
Earnings From Equity Interest Net Of Tax	-	-	-	-	-	-
Net Income Common Stockholders	-	$ -24.63M	$ -14.76M	$ -12.69M	$ -21.43M	$ -24.05M
Basic EPS	-	$ -34.17	$ -1.30	$ -1.70	$ -0.06	-
Diluted EPS	-	$ -34.17	$ -45.50	$ -1.70	$ -0.06	-
Basic Average Shares	-	$ 720.85K	$ 324.45K	$ 7.35M	$ 387.50M	-
Diluted Average Shares	-	$ 720.85K	$ 324.45K	$ 7.35M	$ 387.50M	-
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	$ 321.00K	$ 379.00K	-
Total Expenses	-	$ 32.38M	$ 17.04M	$ 16.90M	$ 18.31M	-
Net Income From Continuing And Discontinued Operation	-	-	$ 14.76M	$ -12.69M	$ -21.43M	$ -24.05M
Normalized Income	-	-	-	$ -12.69M	$ -21.43M	$ -24.05M
Interest Expense	-	-	-	$ 750.00K	$ 5.49M	$ 1.41M
EBIT	-	$ 10.69M	$ 2.68M	$ -11.96M	$ -17.87M	$ -23.13M
EBITDA	-	$ 11.90M	$ 1.94M	$ -8.40M	$ -15.00M	$ -19.43M

Currency in USD

G Medical Innovations Holdings Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing